GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro

We report that GRL-09510, a novel HIV-1 protease inhibitor (PI) containing a newly-generated P2-crown-tetrahydrofuranylurethane (Crwn-THF), a P2′-methoxybenzene, and a sulfonamide isostere, is highly active against laboratory and primary clinical HIV-1 isolates (EC(50): 0.0014–0.0028 μM) with minima...

Descripción completa

Detalles Bibliográficos
Autores principales: Amano, Masayuki, Miguel Salcedo-Gómez, Pedro, Yedidi, Ravikiran S., Delino, Nicole S., Nakata, Hirotomo, Venkateswara Rao, Kalapala, Ghosh, Arun K., Mitsuya, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613016/
https://www.ncbi.nlm.nih.gov/pubmed/28947797
http://dx.doi.org/10.1038/s41598-017-12052-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613016/
https://www.ncbi.nlm.nih.gov/pubmed/28947797
http://dx.doi.org/10.1038/s41598-017-12052-9

Ejemplares similares